Davenport & Co LLC
- SEC CIK
- 0000887777
- Latest filing
- Jul 13, 2026
NKTR holding history
Nektar Therapeutics in every 13F filed by Davenport & Co LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NKTR overviewAll 13F holders of NKTRFull Q2 2026 holdings
- Shares (Q2 2022)
- 0
- Sold out in Q2 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2022 | 0 | $0 | 0.0% | −47,300−100.0% | Sold out | Holders |
| Q1 2022 | 47,300 | $255.0K | <0.1% | −1,500−3.1% | Reduced | Holders |
| Q4 2021 | 48,800 | $659.0K | <0.1% | −20,521−29.6% | Reduced | Holders |
| Q3 2021 | 69,321 | $1.24M | <0.1% | +10,000+16.9% | Added | Holders |
| Q2 2021 | 59,321 | $1.01M | <0.1% | −4,979−7.7% | Reduced | Holders |
| Q1 2021 | 64,300 | $1.29M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.